Gaithersburg, MD – September 9, 2015 – MedImmune, the global biologics research and development arm of AstraZeneca, and Nobel Media, which shares inspirational stories of Nobel Laureates with a global audience, will host Nobel Laureate Dr. Randy Schekman on Thursday, Sept. 10th as part of the Nobel Prize Inspiration Initiative (NPII). The event will be held at MedImmune and is part of a global program that brings together Nobel Laureates, young scientists and the local academic community to inspire and engage scientists at all stages of their careers.
In 2013, Dr. Schekman was awarded the Nobel Prize in Physiology or Medicine along with Dr. James Rothman of Yale University and Dr. Thomas Südhof of Stanford University for their research in cellular transport systems. Dr. Schekman is a Professor in the Department of Molecular and Cell Biology at the University of California, Berkeley, and an Investigator at the Howard Hughes Medical Institute. In addition to his many scientific accolades, Dr. Schekman serves as Editor-in-Chief of the open access journal eLife, which provides unrestricted online access to scientific publications.
“Our talented scientists are passionate about developing innovative medicines that address serious diseases and life-changing conditions,” said Bahija Jallal, Executive Vice President, MedImmune. “The Nobel Prize Inspiration Initiative shares this same passion and works to unite the global scientific community in pursuit of this goal. MedImmune is honored that we will have the opportunity to hear from and learn from Dr. Schekman at this year’s program.”
Dr. Schekman will take part in several round-table sessions with researchers from MedImmune, the National Institutes of Health (NIH) and local universities to discuss topics such as scientific collaborations and the challenges facing young scientists. In the afternoon, his keynote lecture will provide insights into his experiences of receiving the Nobel Prize, and touch on his Nobel Prize-awarded research into how cells transport proteins. Disturbances in the cellular transport of proteins occur in a variety of diseases, including immunological disorders, diabetes and neurological diseases. Dr. Schekman will also participate in an on-stage interview about the future of science publishing, including the impact of open access publishing.
The following day, Dr. Schekman will visit local universities in Baltimore to give lectures and participate in roundtable discussions with students from the universities and local high schools.
Speaking in advance of the event, Dr. Schekman stated, “The decisions a young scholar makes at an early stage are crucial in establishing the foundation of a career in research, teaching and leadership. I look forward to sharing my views and hearing about the plans and concerns of the young scientists who participate in this event.”
If you are a member of the media and would like to register for Dr. Schekman’s lecture, please contact Tracy Rossin at email@example.com.
Short video clips of Dr. Schekman will be recorded at the event and posted on the Nobel Prize Inspiration Initiative website (www.nobelprizeii.org). To receive copies of the videos, please contact firstname.lastname@example.org.
This Initiative is organized by Nobel Media in partnership with MedImmune and AstraZeneca, a global innovation-driven biopharmaceutical company that focuses on scientific leadership as a key strategic priority.
NOTES TO EDITORS
MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. The MedImmune headquarters is located in Gaithersburg, Md, one of AstraZeneca’s three global R&D centers. For more information, please visit www.medimmune.com.
About Nobel Media AB
Nobel Media spreads knowledge about Nobel Prize-awarded achievements and stimulates interest in science, literature and peace in line with Alfred Nobel’s vision and legacy. The company reaches a global audience of millions through its high-quality productions within broadcast and digital media which includes the official Nobelprize.org website and podcast, the Nobel Prize Concert, as well as a series of intercontinental, inspirational lecture events featuring Nobel Laureates. The company also manages a portfolio of publishing licenses, footage sales, and live broadcast rights to the Nobel Prize Award Ceremonies.
Please visit: www.nobelprize.org, Twitter: @NobelPrize, Facebook: www.facebook.com/Nobelprize.org, YouTube: www.youtube.com/nobelprize, Google +: plus.google.com/+NobelPrize
Nobel Media®, Nobel Prize® and Nobelprize.org® are registered trademarks of the Nobel Foundation. Disclaimer: Nobel Media AB is not directly or indirectly involved in the process of nominating or selecting Nobel Laureates. These procedures are strictly confidential and regulated by the Nobel Prize awarding institutions.
Nobel Media® and Nobel Prize® are registered trademarks of the Nobel Foundation. Nobel Media is neither directly nor indirectly involved in the process of nominating or selecting Nobel Laureates. These procedures are strictly confidential and regulated independently by the different Nobel Prize-awarding institutions.
About the Nobel Prize Inspiration Initiative
The Nobel Prize Inspiration Initiative (NPII) is a global programme designed to help Nobel Laureates share their inspirational stories and insights. By taking Nobel Laureates on visits to universities and research centres around the world, and by capturing their thoughts on video, the Initiative seeks to bring the Laureates into closer contact with the worldwide scientific community, and especially with an audience of young scientists.
The Initiative is organised by Nobel Media, the company managing media rights for the Nobel Prize, in partnership with AstraZeneca, a global innovation-driven biopharmaceutical company that focuses on scientific leadership as a key strategic priority, and MedImmune.
Please visit: www.nobelprizeii.org, Twitter: @NobelPrizeii, Facebook: https://www.facebook.com/NobelPrizeInspirationInitiative, YouTube: www.youtube.com/nobelprizeii
Tracy Rossin, MedImmune
Rebecca Nesbit, Nobel Media
+44 (0)207 428 0822
+44 (0)7496 919476